A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty - Université de Bretagne Occidentale Access content directly
Journal Articles The Bone & Joint Journal (BJJ) Year : 2019

A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

A. Clavé
  • Function : Author
CHRU Brest - Service chirurgie orthopédique et traumatologique
R. Gérard
  • Function : Author
J. Lacroix
  • Function : Author
C. Baynat
  • Function : Author
M. Danguy Des Déserts
CV
F. Gatineau
  • Function : Author
CIC Brest
D. Mottier
  • Function : Author
Groupe d'Etude de la Thrombose de Bretagne Occidentale
CIC Brest

Domains

Life Sciences [q-bio] Human health and pathology Surgery Cardiology and cardiovascular system

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02059406

Submitted on : Wednesday, March 6, 2019-3:50:48 PM

Last modification on : Tuesday, October 3, 2023-10:38:03 AM

No file

Dates and versions

hal-02059406 , version 1 (06-03-2019)

Identifiers

Cite

A. Clavé, R. Gérard, J. Lacroix, C. Baynat, M. Danguy Des Déserts, et al.. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. The Bone & Joint Journal (BJJ), 2019, 101-B (2), pp.207-212. ⟨10.1302/0301-620X.101B2.BJJ-2018-0898.R1⟩. ⟨hal-02059406⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST GETBO IBSAM
32 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More